1. Ford, C. E., Jacobs, P. A., and Lajtha, L. G. Human somatic chromosomes. Nature (London) 181:1565-1568, 1958.

2. Ford, C. E., Jones, K. W., Polani, P. E., Almeida, J. C. D. E., and Briggs, J. H. A sex chromosomal anomaly in a case of gonadal dysgenesis (Turner's syndrome). Lancet 1:711-713, 1959.

3. Lejeune, J., Gautier, M., and Turpin, R. Etudes des chromosomes somatiques de neuf enfants mongoliens. C. R. Acad. Sci. 248: 1721-1722, 1959.

4. Nowell, P. C. and Hungerford, D. A. A minute chromosome in human chronic granulocytic leukemia. Science 132:1497-1499, 1960.

5. Comings, D. E. Mechanisms of chromosome banding and implications for chromosome structure. Annu. Rev. Genet. 12:25-46, 1978.

6. Caspersson, T., Lomakka, G., and Zech, L. The 24 fluorescence patterns of the human metaphase chromosomes-distinguishing characters and variability. Hereditas 67:89-102, 1971.

7. Chaudhuri, J. P., Vogel, W., Voiculescu, I., and Wolf, U. A simplified method of demonstrating Giemsa-band pattern in human chromosomes. Humangenetik 14:83-84, 1971.

8. Rowley, J. D. A new consistent chromosomal abnormality in chronic myelogenous leukemia. Nature 243:290-293, 1973.

9. Rowley J. D., Golomb, H. M., Vardiman, J., Fukuhara, S., Dougherty, C., and Potter, D. Further evidence for a nonrandom chromosomal abnormality in acute promyelocytic leukemia. Int. J. Cancer 20:869-872, 1977.

10. Sozzi, G., Testi, M. A., and Croce, C. M. Advances in cancer cytogenetics. J. Cell. Biochem. 32/33 (Suppl.), 173-182. 1999.

11. Kjeldsen, E. and K0lvaraa, S. FISH technique, FISH probes and their applications in medicine and biology-an overview, in FISH Technology, (Rautenstrauß, B. and Liehr, T., edS.,) Springer-Verlag, Berlin, pp. 3-50, 2002.

12. Buongiorno-Nardelli, M. and Amaldi, F. Autoradiographic detection of molecular hybrids between rRNA and DNA in tissue sections. Nature 225:946-947, 1969.

13. Gall, G. and Pardue, M. L. Formation and detection of RNA-DNA hybrid molecules cytological preparations. Proc. Natl. Acad. Sci., USA 63:378-381, 1969.

14. John, H. L., Birnstiel, M. L., and Jones, K. W. RNA-DNA hybrids at the cytological level. Nature 223: 912-913, 1969.

15. Pinkel, D., Straume, T., and Gray, J. W. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc. Natl. Acad. Sci, USA 83:2934-2938, 1986.

16. Deaven, L. L., Van Dilla, M. A., Bartholi, M. F., et al. Construction of human chromosome specific DNA libraries from flow sorted chromosomes. Cold Spring Harb. Symp. Quant. Biol. 51:159-167, 1986.

17. Cremer, T., Landegent, J., Brückner, A., et al. Detection of chromosome aberrations in the human interphase nucleus by visualization of specific target DNAs with radioactive and non-radioactive in situ hybridization techniques: diagnosis of trisomy 18 with probe L1.84. Hum. Genet. 74:346-352, 1986.

18. Pinkel D., Landegent, J., Collins, C., et al. Fluorescence in situ hybridization with human chromosome specific libraries: detection of trisomy 21 and translocation of chromosome 4. Proc. Natl. Acad. Sci. USA 85:9138-9142, 1988.

19. Kearney, L. The impact of the new FISH technologies on the cyto-genetics of hematological malignancies. Br. J. Haematol. 104:648658, 1999.

20. McNicol, A. M. and Farquharson, M. A. In situ hybridization and its diagnostic applications in pathology. J. Pathol. 182:250-261, 1997.

21. Weiss, L. M. and Chen, Y. Y. Effects of different fixatives on detection of nucleic acids from paraffin-embedded tissues by in situ hybridization using oligonucleotide probes. J. Histochem. Cytochem. 39:1237-1241, 1991.

22. Karlsen, F., Kalantari, M., Chitemerere, M. Johansson, B., and Hagmar, B. Modifications of human and viral deoxynucleic acid by formaldehyde fixation. Lab. Invest. 71:604-611, 1994.

23. Basyuk, E., Bertrand, E., and Journot, L. Alkaline fixation drastically improves the signal of in situ hybridization. Nucleic Acids Res. 28:e46, 2000.

24. Abati, A., Sanford, J. S., Fetsch, P., Marincola, F. M., and Wolman, S. R. Fluorescence in situ hybridization (FISH): a user's guide to optimal preparation of cytologic specimens. Diagn. Cytopathol. 13:486-492, 1995.

25. Oliver, K. R., Heavens, R. P., and Sirinathsinghji, D. J. S. Quantitative comparison of pretreatment regimens used to sensitize in situ hybridization using oligonucleotide probes on paraffin-embedded brain tissues. J. Histochem. Cytochem. 45:1707-1713, 1997.

26. Henke, R. P. and Ayhan, N. Enhancement of hybridization efficiency in interphase cytogenetics on paraffin-embedded tissue sections by microwave treatment. Anal. Cell Pathol. 6:319-325, 1994.

27. Qian, X., Bauer, R. A., Xu, H. S., and Lloyd, R.V. In situ hybridization detection of calcitonin mRNA in routinely fixed, paraffin-embdded tissue sections: a comparison of different types of probes combined with tyramide signal amplification. Appl. Immunohistochem. Mol. Morphol. 9:61-69, 2001.

28. McQuaid, S., McMahon, J., and Allan, G. M. A comparison of digoxigenin and biotin labeled DNA and RNA probes for in situ hybridization. Biotech. Histochem. 70:147-154, 1995.

29. Komminoth, P., Merk, F. B., Leav, I., Wolfe, H. J., and Roth, J. Comparison of 35S- and digoxigenin-labeled RNA and oligonucleotide probes for in situ hybridization: expression of mRNA of the seminal vesicle protein II and androgen receptor genes in the rat prostate. Histochemistry 98:217-228, 1992.

30. Brousset, P., Butet, V., Chittal, S., Selves, J., and Delsol, G. Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohistochemical correlation with anti-latent membrane protein antibody. Lab. Invest. 67:457-464, 1992.

31. Höfler, H. Principles of in situ hybridization, in (In Situ) Hybridization: Principles and Practice, Polak, J. M. and McGee, J.O'D., eds.) Oxford University Press, Oxford, pp. 15-30, 1990.

32. van Stedum, S. and King, W. Basic FISH techniques and troubleshooting. Methods Mol. Biol. 204:51-63, 2002.

33. Werner, M., Wilkens, L., Aubele, M., Nolte, M., Zitzelsberger, H., and Komminoth, P. Interphase cytogenetics in pathology: principles, methods, and applications of fluorescence in situ hybridization (FISH). Histochem. Cell Biol. 108:381-390, 1997.

34. Rigolin, G. M., Howard, J., Buggins, A., et al. Phenotypic and functional characteristics of monocyte-derived dendritic cells from patients with myelodysplastic syndromes. Br. J. Haematol. 107:844-850, 1999.

35. Bigoni, R., Cuneo, A., Milani, R., et al. Multilineage involvement in the 5q- syndrome: a fluorescent in situ hybridization study on bone marrow smears. Hematologica 86:375-381, 2001.

36. Wolfe, K. Q. and Herrington, C. S. Interphase cytogenetics and pathology: a tool for diagnosis and research. J. Pathol. 181: 359-361, 1997.

37. Dewald, G. W. Interphase FISH studies of chronic myeloid leukemia. Methods Mol. Biol. 204:311-342, 2002.

38. Tönnies, H. Modern molecular cytogenetics techniques in genetic diagnostics. Trends Mol. Med. 8:246-250, 2002.

39. Lawce, H., Durum, C., Unsworth, N., Olson, S., and Magenis, R. E. BCR-ABL FISH: probes, patterns and prognoses. J. Assoc. Genet. Tech. 28:40-46, 2002.

40. Wang, S., Saboorian, M. H., Frenkel, E. P., et al. Aneusomy 17 in breast cancer: its role in HER2/neu protein expression and implication for clinical assessment of HER2/neu status. Mod. Pathol. 15:137-145, 2002.

41. McCormick S. R., Lillemoe, T. J., Beneke, J., Schrauth, J., and Reinartz, J. HER2 assessment by immunohistochemical analysis and fluorescence in situ hybridization. Anat. Pathol. 117:935-943, 2002.

42. Jalal, S. M., Law, M. E., Christensen, E. R., Spurbeck, J. L., and Dewald, G. W. Method for sequential staining of GTL-banded metaphases with fluorescent-labeled chromosome specific paint probes. Am. J. Med. Genet. 46:98-103, 1993.

43. Speicher, M. R., Ballard, S. G., and Ward, D.C. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nature Genet. 12:368-375, 1996.

44. Schröck, E., du Manior, S. Veldman, T., et al. Multicolor spectral karyotyping of human chromosomes. Science 273:494-497, 1996.

45. Tanke, H.J., Wiegant, J., van Gijlswijk, R.P., et al. New strategy for multi-colour fluorescence in situ hybridization: COBRA: combined binary ratio labeling. Eur. J. Hum. Genet. 7:2-11, 1999.

46. Barbouti, A., Johansson, B., Hoglund, M., et al. Multicolor COBRA-FISH analysis of chronic myeloid leukemia reveals novel cryptic balanced translocations during disease progression. Genes Chromosomes Cancer 35:127-137, 2002.

47. Zitzelsberger, H., Lehman, L., Werner, M., and Bauchinger, M. Comparative genomic hybridization for the analysis of chromosomal imbalances in solid tumors and haematological malignancies. Histochem. Cell Biol. 108:403-417, 1997.

48. Caburet, S., Conti, C., and Bensimon, A. Combing the genome for genomic instability. Trends Biotech. 20:344-350, 2002.

49. Saracoglu, K., Brown, J., Kearney, L., et al. New concepts to improve resolution and sensitivity of molecular cytogenetics diagnostics by multicolor fluorescence in situ hybrodization. Cytometry 44:7-15, 2001.

50. Solinas-Toldo, S., Lampel, S., Stilgenbauer, S., et al. Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 20:399-407, 1997.

51. Snijders A. M., Nowak, N., Segraves, R., et al. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat. Genet. 29:263-264, 2001.

52. Rapp, A.K., Florijn, R.J., Blonden, L.A.J., et al. Fiber FISH as a DNA mapping tool. Methods 9:67-73, 1996.

53. Heng, H. H. Q. and Tsui, L. C. High resolution free chromatin/DNA fiber fluorescent in situ hybridization. J. Chromatogr. 806:219-229, 1998.

54. Komminoth, P. and Werner, M. Target and signal amplification: approaches to increase the sensitivity of in situ hybridization. Histochem. Cell Biol. 108:325-333, 1997.

55. Koch, J., Mogensen, J., Pedersen, S., et al. Fast one-step procedure for the detection of nucleic acids in situ by primer-induced sequence-specific labeling with fluorescein-12-dUTP. Cytogenet. Cell Genet. 60:1-3, 1992.

56. Haase, A. T., Retzel, E. F., and Staskus, K. A. Amplification and detection of lentiviral DNA inside cells. Proc. Natl. Acad. Sci., USA 87:4971-4975, 1990.

57. Bobrow, M. N., Harris, T. D., Shaughnessy, K. J., and Litt, G. J. Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassay. J. Immunol. Methods 125:279-285, 1989.

58. van Gijlswijk, R. P. M., Zijlmans, H. J. M. A. A., Wiegant, J., et al. Fluorochrome-labeled tyramides: use in immunohistochemitry and fluorescence in situ hybridization. J. Histochem. Cytochem. 45:375-382, 1997.

59. van de Corput, M. P. C., Dirks, R. W., et al. Sensitive mRNA detc-tion by fluorescence in situ hybridization using horseradish peroxi-dase-labeled oligodeoxynucelotides and tyramide signal amplification. J. Histochem. Cytochem. 46:1249-1259, 1998.

60. Speel, E. J. M., Ramaekers, F. C. S., and Hopman, A. H. N. Sensitive multicolor fluorescence in situ hybridization using catalyzed reporter deposition (CARD) amplification. J. Histochem. Cytochem. 45:1439-1446, 1997.

61. Stumm, M., Tönnies, H., and Wieacker, P. F. Molecular cytogenet-ics techniques for the diagnosis of chromosomal abnormalities in childhood disease. Eur. J. Pediatr. 158:531-536, 1999.

62. Johansson, B., Mertens, F., and Mitelman, F. Primary vs. secondary neoplasia-associated chromosomal abnormalities—balanced rearrangements vs. genomic imbalances? Genes Chromosomes Cancer 16:155-163, 1996.

63. Mitelman, F. Recurrent chromosome aberrations in cancer. Mutat. Res. 462:247-253, 2000.

64. Slupianek, A., Hoser, G., Majsterek, I., et al. Fusion tyrosine kianses induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G2/M phase, and protection from apoptosis. Mol. Cell. Biol. 22:4189-4201, 2002.

65. Grimwade, D. and Coco, F. L. Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia. Leukemia 16:1959-1973, 2002.

66. Wessels, P. H., Hopman, A. H. N., Ummelen, M. I .J., Krijne-Kubat, B., Ramaekers, F. C. S. and Twijnstra, A. Differentiation between reactive gliosis and diffuse astrocytoma by in situ hybridization. Neurology 56:1224-1227, 2001.

67. Padua R. A., McGlynn, A., and McGlynn, H. Molecular, cytogenetics and genetic abnormalities in MDS and secondary AML, in Myelodysplastic Syndromes and Secondary Acute Myelogenous Leukemia, Raza, A. and Mundle, S., eds., Kluwer, Boston, pp. 111-158,2001.

68. Greenberg, P. L., Cox, C., LeBeau, M. M., et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89:2079-2088, 1997.

69. Fonseca, R., Blood, E., Rue, M., et al. Clinical and biological implications of recurrent genomic aberrations in myeloma. Blood. 101:4569-4575, 2003.

70. Masood, S. and Bui, M. M. Prognostic and predictive value of HER2/neu oncogene in breast cancer. Microsc. Res. Tech. 59:102-108,2002.

71. Carlomagno, C., Perrone, F., Gallo, C., et al. c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases. J.Clin. Oncol. 14:2702-2708, 1996.

72. Bianco, A.R., De Laurentiis, M., Carlomagno, C.,et al. 20 year update of the Naples GUN trial of adjuvant breast cancer. Proc. Am. Soc. Clin. Oncol. 17:373, 1998.

73. Slamon, D., Leyland-Jones, B., Shak, S., et al. Addition of Herceptin (humanized anti-HER-2 antibody) to first line chemotherapy for HER2 overexpressing metastatic breast cancer markedly increases anticancer activity: A randomized multinational controlled Phase III trial. Proc. Am. Soc. Clin. Oncol. 17:377, 1998.

74. Sarosdy, M. F., Schellhammer, P., Bokinsky, G.,et al. Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer. J. Urol. 168:1950-1954,2002.

75. Wang, Y. L., Bagg, A., Pear, W., Nowell, P. C., and Hess, J. L. Chronic myelogenous leukemia: laboratory diagnosis and monitoring. Genes Chromosomes Cancer 32:97-111, 2001.

76. Kantarjian, H. M., Smith, T. L., O'Brien, S., Beran, M., Pierce, S., and Talpaz, M. Prolonged survival in chronic myelogenous leukemia after cytogenetics response to interferon-alpha therapy. The leukemia service. Ann. Intern. Med. 122:254-261, 1995.

77. Druker, B. J., Talpaz, M., Resta, D., et al. Clinical efficacy and safety of an ABL specific tyrosine kinase inhibitor as targeted therapy for chronic myelogenous leukemia. Blood 94(Suppl.), 368a, 1999.

78. Tanaka, K., Arif, M., Eguchi, M., et al. Interphase fluorescence in situ hybridization overcomes pitfalls of G-banding analysis with special reference to underestimation of chromosomal aberration rates. Cancer Gene. Cytogenet. 115:32-38, 1999.

79. Manicini, M., Nani, M., Cedrone, M.,et al. Combined cytogenetics, FISH and molecular analysis in acute promyelocytic leukemia at diagnosis and complete remission. Br. J. Haematol. 91:878-884, 1995.

80. Knuutila, S., Elonen, E., Teerenhovi, L., et al.Trisomy 12 in B cells of patients of B-cell chronic lymphocytic leukemia. N. Engl. J. Med. 314:865-869, 1996.

81. Grimwade, I. S., Chase, D., Goldstone, A., Burnett, A. H., Goldman, A. K., and Swirsky, J. M. Identification of PML/RAR alpha rearrangements in suspected acute promyelocytic leukemia (APL) using in situ hybridization on bone amrrow smears: a comparison of cytogenetics with RT-PCR in MRC ATRA trial patients. Br. J. Haematol. 101(suppl.):35, 1998.

82. McNicol, A. M., Farquharson, M. A., Lee, F. D., and Foulis, A. K. Comparison of in situ hybridization and polymerase chain reaction in diagnosis of B cell lymphoma. J. Clin. Pathol. 51:229-233, 1998.

83. Belaud-Rotureau, M. A., Parrens, M., Dubus, P., Garroste, J. C., de Mascarel, A., and Merlino, J. P. A comparative analysis of FISH, RT-PCR, PCR and immunohistochemistry for the diagnosis of mantle cell lymphomas. Mod. Pathol. 15:517-525, 2002.

84. Gleißner, B., Rieder, H., Thiel, E., et al. Prospective BCR-ABL, analysis by polymerase chain reaction (RT-PCR) in adult acute B-lineage lymphoblastic leulemia: reliability of RT-nested PCR and comparison to cytogenetics data. Leukemia 15:1834-1840, 2001.

85. Kim, Y. J., Kim, D. W., Lee, S., et al. Comprehensive comparison of FISH, RT-PCR, and RQ-PCR for monitoring the BCR-ABL gene after hematopoietic stem cell transplantation in CML. Eur. J. Haematol. 68:272-280, 2002.

86. Gladstone, B., Sivaraman, S., Venugopal, P., et al. Measurement of telomerase activity in cytogenetically marked AML cells could be useful in determining response to therapy. Blood 98:2439, 2001.

87. Ambre-Kadam, P. S., Baisane, C., Saikia, T., Nair, R., Gawade, H., and Advani, S. Fluorescence in situ hybridization: a highly efficient technique of molecular diagnosis and prediction for disease course in patients with myeloid leukemias. Cancer Genet. Cytogenet. 131:125-134,2001.

88. Nilsson M., Krjeci, K., Koch, J., Kwaitkowski, M., Gustavson, P. and Landegren, U. Padlock probes reveal single-nucleotide differences, parent of origin and in situ distribution of centromeric sequences in human chromosomes 13 and 21 Nat. Genet. 16:252-255, 1997

89. Varella-Garcia, M. Molecular cytogenetics in solid tumors: labora-torial tool for diagnosis, prognosis and therapy. Oncologist 8:45-58, 2003.

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment